Skip to main content
Clinical Trials/ISRCTN14900339
ISRCTN14900339
Completed
未知

Pilot for interventional diabetes self-management education service

Optimum Health Innovations Ltd0 sites12 target enrollmentMay 31, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Optimum Health Innovations Ltd
Enrollment
12
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 31, 2016
End Date
September 1, 2016
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Optimum Health Innovations Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged \=18\-75 years old
  • 2\. A confirmed diagnosis of T2DM within the last year treated by metformin and/or lifestyle
  • 3\. A body mass index of 22\-45 kg/m2
  • 4\. Willingness to undertake a structured education programme for 6 weeks
  • 5\. Willingness to attend the course venue at specified times on 6 separate occasions
  • 6\. Ability to read, write and converse in English without the support of an interpreter
  • 7\. Familiar with internet and Smartphone use and with regular access to a connected computer

Exclusion Criteria

  • 1\. Inability to provide informed consent
  • 2\. Unwillingness or inability to perform any of the study components required, specifically self\-monitoring of blood glucose (finger\-stick SMBG) or oral glucose tolerance test (OGTT)
  • 3\. Any contra\-indication for weight loss
  • 4\. Type 1 diabetes mellitus (T1DM) or diagnosed with T2DM \> 1 years
  • 5\. Currently prescribed insulin, thiazolidenediones or sulfonylurea.
  • 6\. Currently prescribed steroids or beta\-blockers
  • 7\. Serum Creatinine \> 150mmol/L
  • 8\. Serum ALT greater than 2\.5 times the upper limit of the reference range
  • 9\. Pregnant or intending to become pregnant
  • 10\. HF or any other existing cardiovascular co\-morbidity

Outcomes

Primary Outcomes

Not specified

Similar Trials